| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.10B | — | +11.9% |
| Cost of Revenue | $1.09B | — | -6.0% |
| Gross Profit | $1.02B | — | +40.7% |
| R&D Expense | $172.0M | — | +10.3% |
| SG&A Expense | $478.0M | — | +0.4% |
| Operating Income | $435.0M | — | +35.5% |
| Pre-tax Income | $342.0M | — | +60.6% |
| Income Tax | $40.0M | — | +14.3% |
| Net Income | $305.0M | — | +65.8% |
| EPS (Basic) | $2.71 | — | +67.3% |
| EPS (Diluted) | $2.69 | — | +67.1% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $444.0M | -5.1% | -5.7% |
| Accounts Receivable | $1.77B | -8.2% | +5.9% |
| Inventory | $1.22B | -2.3% | -1.3% |
| Current Assets | $3.99B | +2.0% | +6.4% |
| Total Assets | $11.23B | +0.1% | +2.6% |
| Current Liabilities | $3.45B | +0.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $234.0M | — | -35.7% |
| Capital Expenditures | $64.0M | — | -9.9% |
| Investing Cash Flow | -$69.0M | — | +16.9% |
| Financing Cash Flow | -$153.0M | — | +39.8% |
| Free Cash Flow | $170.0M | — | -42.0% |
| -0.7% |
| Long-term Debt | $2.57B | -1.5% | +0.4% |
| Stockholders' Equity | $3.75B | +2.5% | +10.7% |